Patent details

Basic Information

Publication number:

EP2442650

PCT Application Number:

PCT/US/2010/038336

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP107869158

PCT Publication Number:

WO/2010/144817

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SUBLINGUAL APOMORPHINE

French Title of Invention:

APOMORPHINE SUBLINGUALE

German Title of Invention:

SUBLINGUALES APOMORPHIN

SPC Number:

Dates

Filing date:

11/06/2010

Grant date:

26/08/2015

EP Publication Date:

26/08/2015

PCT Publication Date:

16/12/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/04/2012

EP B1 Publication Date:

26/08/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/06/2016

Expiration date:

11/06/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

30/12/2016

 

 

Name:

Sunovion Pharmaceuticals Inc.

Address:

84 Waterford Drive, Marlborough, MA 01752, United States (US)

Inventor

1

Name:

HEDDEN David, Bruce

Address:

United States (US)

2

Name:

BRYSON Nathan, John

Address:

Canada (CA)

3

Name:

GIOVINAZZO Anthony, John

Address:

Canada (CA)

4

Name:

DE SOMER Marc, L.

Address:

United States (US)

Priority

Priority Number:

186445 P

Priority Date:

12/06/2009

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/473;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages